These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7857315)

  • 41. Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs.
    Gratton JP; Rae GA; Claing A; Télémaque S; D'Orléans-Juste P
    Br J Pharmacol; 1995 Feb; 114(3):720-6. PubMed ID: 7735698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diuretic-natriuretic actions and pressor effects of big-endothelin (1-39) in phosphoramidon-treated rats.
    Hoffman A; Haramati A; Dalal I; Shuranyi E; Winaver J
    Proc Soc Exp Biol Med; 1994 Feb; 205(2):168-73. PubMed ID: 8108467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CGS 34043: a non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
    Trapani AJ; De Lombaert S; Beil ME; Bruseo CW; Savage P; Chou M; Jeng AY
    Life Sci; 2000; 67(9):1025-33. PubMed ID: 10954036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benzofused macrocyclic lactams as triple inhibitors of endothelin-converting enzyme, neutral endopeptidase 24.11, and angiotensin-converting enzyme.
    Ksander GM; Savage P; Trapani AJ; Balwierczak JL; Jeng AY
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S71-3. PubMed ID: 9595404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle.
    Maguire JJ; Johnson CM; Mockridge JW; Davenport AP
    Br J Pharmacol; 1997 Dec; 122(8):1647-54. PubMed ID: 9422810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A; Neugebauer W; Yano M; Rae GA; D'Orléans-Juste P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
    Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of biological actions of big endothelin-1 by phosphoramidon.
    Fukuroda T; Noguchi K; Tsuchida S; Nishikibe M; Ikemoto F; Okada K; Yano M
    Biochem Biophys Res Commun; 1990 Oct; 172(2):390-5. PubMed ID: 2241940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
    Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
    Liu W; Takayanagi R; Ito T; Oba K; Nawata H
    FEBS Lett; 1997 Dec; 420(1):103-6. PubMed ID: 9450558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guinea pig Clara cells secrete endothelin 1 through a phosphoramidon-sensitive pathway.
    Laporte J; D'Orléans-Juste P; Sirois P
    Am J Respir Cell Mol Biol; 1996 Apr; 14(4):356-62. PubMed ID: 8600940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.
    Matsumura Y; Hisaki K; Takaoka M; Morimoto S
    Eur J Pharmacol; 1990 Aug; 185(1):103-6. PubMed ID: 2226629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular pharmacology of endothelin converting enzymes.
    Turner AJ; Murphy LJ
    Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential inhibition of wild-type endothelin-converting enzyme-1 and its mutants.
    Savage P; De Lombaert S; Shimada K; Tanzawa K; Jeng AY
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S16-8. PubMed ID: 9595388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
    Matsumoto T; Ozawa Y; Taguchi K; Kobayashi T; Kamata K
    Peptides; 2010 Feb; 31(2):346-53. PubMed ID: 19962413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.
    Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
    FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme.
    Ikegawa R; Matsumura Y; Tsukahara Y; Takaoka M; Morimoto S
    Biochem Biophys Res Commun; 1990 Sep; 171(2):669-75. PubMed ID: 2206130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme.
    Morita A; Nomizu M; Okitsu M; Horie K; Yokogoshi H; Roller PP
    FEBS Lett; 1994 Oct; 353(1):84-8. PubMed ID: 7926029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of endothelin in the realization of the length-strength ratio of vascular smooth muscles in rats].
    Tkachenko MN; Sagach VF
    Fiziol Zh Im I M Sechenova; 1995 Sep; 81(9):60-4. PubMed ID: 8581054
    [No Abstract]   [Full Text] [Related]  

  • 60. Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.
    D'Orléans-Juste P; Télémaque S; Claing A
    Br J Pharmacol; 1991 Oct; 104(2):440-4. PubMed ID: 1797310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.